Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Neoplasia (New York, N.Y.)|May 31, 2016
IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor RecurrenceKelsey A Finkel, Kristy A Warner, Samuel Kerk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell CarcinomaSamuel A Kerk, Kelsey A Finkel, Alexander T Pearson, et al.
The Journal of Clinical Investigation|January 17, 2018
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regressionHeng Lin, Shuang Wei, Elaine M Hurt, et al.
Immunity|September 4, 2004
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiationA L Shaffer, Miriam Shapiro-Shelef, Neal N Iwakoshi, et al.
Genome Biology|October 13, 2001
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridolL T Lam, O K Pickeral, A C Peng, et al.
Molecular Cancer Therapeutics|May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive CellsRuoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Cancer Cell|August 19, 2007
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myelomaChristina M Annunziata, R Eric Davis, Yulia Demchenko, et al.
The Journal of Clinical Investigation|September 19, 2023
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer modelsSupreet Agarwal, Lei Fang, Kerry McGowen, et al.
Molecular Cancer Therapeutics|May 20, 2017
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4Jay Harper, Christopher Lloyd, Nazzareno Dimasi, et al.
Cancer Cell|March 7, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaAndreas Rosenwald, George Wright, Adrian Wiestner, et al.
Pageof 13